Yes, this is the requirement. Definitively for Class III and implantable devices, but in general, the bar has been raised on equivalence. Be prepared to make a more robust justification for equivalence for all devices. Further, consider leveraging your post-market surveillance data. This can include things like customer surveys, focus groups, and other proactive activities to gain understanding of the device. This will be one of the biggest challenges and has many companies nervous.
